EUVIMEDEUVIMED entdecken
Crossref

Atorvastatin‐Loaded Mineralized Vaccine Reprograms Endosomal Trafficking to Amplify STING‐Driven Cancer Immunotherapy

Yuhan Yang, Wei Long, Xiangyu Pei, Shangfei Li, Bowen Fu, Hao Zhai, Xiaoyi Zhang, Ying Wan, Yayun Peng iD, Ting Cai iD

Angewandte Chemie International Edition · 2025

DOI: 10.1002/anie.202503749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Yuhan Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Na…. Hauptthemen laut MEDLINE: Endosomes, Immunotherapy, Cancer Vaccines, Membrane Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dendritic cell (DC)‐targeted nanovaccines offer great promise for cancer immunotherapy but are severely limited by premature lysosomal degradation of antigens, which reduces cross‐presentation efficacy. Here, we report a facile yet effective biomineralization strategy to construct nanovaccine (OVA‐ATV@MnO₂) that co‐delivers ovalbumin (OVA) and atorvastatin (ATV) within MnO₂ matrix. The ATV‐mediated nanovaccine reprograms endosomal trafficking by inhibiting the mevalonate (MVA) pathway, thereby delaying endosomal maturation and preventing antigen diversion to degradative lysosomes. This intervention significantly enhances antigen preservation and MHC‐I presentation in DCs. Simultaneously, the MnO₂ framework not only stabilizes the vaccine nanostructure but also releases Mn 2 ⁺ ions as an adjuvant to potently activate the cGAS‐STING pathway, amplifying DC maturation and antitumor T‐cell priming. In vivo studies demonstrate that the nanovaccine induces robust tumor regression, suppresses metastasis, and establishes durable prophylactic immunity. By synergistically rewiring intracellular antigen trafficking and amplifying STING‐mediated immune activation, this mineralized vaccine platform provides a transformative strategy for precise cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndosomesImmunotherapyCancer VaccinesMembrane ProteinsAtorvastatinNeoplasmsAnimalsMiceOvalbuminHumansDendritic CellsMice, Inbred C57BL

Stichwörter der Autor:innen

Amplify immunotherapyAntigen presentationDC maturationEndosomal reprogrammingSTING activation

Substanzen

Cancer VaccinesMembrane ProteinsAtorvastatinOvalbumin

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198, P.R. China.

ORCID-Profile: Yayun Peng, Ting Cai

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, Y., Long, W., Pei, X., Li, S., Fu, B., Zhai, H., Zhang, X., Wan, Y., Peng, Y., & Cai, T. (2025). Atorvastatin‐Loaded Mineralized Vaccine Reprograms Endosomal Trafficking to Amplify STING‐Driven Cancer Immunotherapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202503749

Vancouver

Yang Y, Long W, Pei X, Li S, Fu B, Zhai H, et al. Atorvastatin‐Loaded Mineralized Vaccine Reprograms Endosomal Trafficking to Amplify STING‐Driven Cancer Immunotherapy. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202503749

BibTeX
@article{Yang2025,
  author = {Yang, Yuhan and Long, Wei and Pei, Xiangyu and Li, Shangfei and Fu, Bowen and Zhai, Hao and Zhang, Xiaoyi and Wan, Ying and Peng, Yayun and Cai, Ting},
  title = {Atorvastatin‐Loaded Mineralized Vaccine Reprograms Endosomal Trafficking to Amplify STING‐Driven Cancer Immunotherapy},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  doi = {10.1002/anie.202503749}
}
Kostenlos starten →